小儿风热清口服液对比小儿咽扁颗粒治疗儿童急性咽炎/扁桃体炎(外感风热证):多中心随机双盲阳性对照非劣效试验方案与统计分析计划
本研究为多中心、随机、双盲、阳性对照、非劣效临床试验,计划纳入120例儿童急性咽炎/扁桃体炎(外感风热证)患者,随机分为小儿风热清口服液组和小儿咽扁颗粒组,疗程5天。主要结局为第5天咽痛消失率和总有效率,采用Wong-Baker面部表情疼痛量表评估。该试验旨在为小儿风热清口服液的非劣效性和安全性提供严谨证据。
要点
- 小儿风热清口服液治疗儿童急性咽炎/扁桃体炎(外感风热证)的非劣效性设计。
- 主要结局为第5天咽痛消失率和总有效率,采用WBS量表评估。
- 样本量120例,每组60例,疗程5天,阳性对照为小儿咽扁颗粒。
核心结论
- 本试验将提供小儿风热清口服液非劣效性和安全性的严谨证据,支持其融入儿童急性上呼吸道感染诊疗。
研究设计与样本
- 多中心、随机、双盲、阳性对照、非劣效临床试验,计划纳入120例(每组60例)儿童急性咽炎/扁桃体炎(外感风热证)患者。
关键数值与推荐
- 主要结局为第5天咽痛消失率和总有效率,采用Wong-Baker面部表情疼痛量表(WBS)评估。
- 次要结局包括症状出现/缓解时间、退热时间和中医证候评分。
- 安全性评估监测不良事件、生命体征和实验室参数。
- 统计分析采用非劣效性检验、生存分析和广义估计方程,缺失数据采用LOCF法(有效性终点)和观察病例分析(安全性)。
临床怎么用
- 本试验结果可为小儿风热清口服液治疗儿童急性咽炎/扁桃体炎(外感风热证)的临床决策提供循证依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the effectiveness and safety of Xiao'er Fengreqing Oral Liquid (XFOL) for pediatric acute pharyngitis/tonsillitis (external wind heat syndrome) through a multi-center, randomized, double-blind, positive-controlled, non-inferiority clinical trial. METHOD: A total of 120 participants (60 per group) will be randomized to receive either XFOL or Xiao'er Yanbian Granules (positive control) for 5 days. The primary outcome is the throat pain resolution rate and overall effective rate at Day 5, assessed via the Wong-Baker Faces Pain Rating Scale (WBS). Secondary outcomes include time to symptom onset/resolution, fever resolution time, and traditional Chinese medicine (TCM) syndrome scores. Safety assessments will monitor adverse events, vital signs, and laboratory parameters. Statistical analyses will follow a pre-specified plan, employing non-inferiority testing, survival analysis for time-to-event endpoints, and generalized estimating equations for repeated measures. Missing data will be handled using the last observation carried forward (LOCF) method for effectiveness endpoints, while safety analyses will rely on observed cases. CONCLUSION: This trial will provide rigorous evidence on the non-inferiority and safety profile of Fengreqing Oral Liquid, supporting its integration into pediatric care for acute upper respiratory infections. Adherence to a predefined statistical analysis plan ensures transparency and minimizes bias, ultimately guiding evidence-based clinical practice for TCM interventions.
引用
- Liu K, Shi L, Song YK, et al. Xiao'er Fengreqing oral liquid versus Xiao'er Yanbian granules for pediatric acute pharyngitis/tonsillitis (external wind heat syndrome): protocol and statistical analysis plan for a multi-center, randomized, double-blind, active drug-controlled trial. Front Pharmacol. 2025. PMID: 40756995. doi:10.3389/fphar.2025.1625547
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。